How AI Helps Develop Cancer Vaccines in Russia - Rosbalt
An article from Rosbalt discusses how artificial intelligence is being used in Russia to develop cancer vaccines. AI accelerates the analysis of genetic mutations and the design of personalized vaccines, although specific details are limited.
The article from Rosbalt explains that artificial intelligence is playing a key role in the development of cancer vaccines in Russia. AI technologies help scientists analyze large volumes of genetic data, identify mutations, and predict the effectiveness of vaccine candidates. This accelerates the process of creating personalized vaccines, which are designed to match the specific genetic profile of a patient's tumor. While the article does not mention specific companies or models, it highlights the growing importance of AI in the field of oncological research in Russia.
Source: GNews RU — ИИ —
original